CYANOTCMedicinal Chemicals & Botanical ProductsFiscal year ends March 31
CYANOTECH CORP
Financials through Q2 FY2026, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 10, 2025
$0.70+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $5.11M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
+$0.4100 (+141.4%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.
CYANOTECH CORP grew revenue 8.5% to $25.27M over the twelve months to Sep 30, 2025.
Revenue
$25.27M
+8.5% vs. a year earlier
Operating income
-$1.06M
TTM Q2 2026
EPS, diluted
-$0.25
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2025
Valuation
- Market cap
- $5.11M
- P/E ratio
- –
- Price to sales
- 0.20
- Price to book
- 0.63
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Revenue
- $25.27M
- Net income
- -$1.78M
- EPS, diluted
- -$0.25
- Book value per share
- $1.11
- Diluted shares
- 7M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$25.27M+8.5% YoY
Gross profit
$8.09M+53.2% YoY
Operating income
-$1.06M
Net income
-$1.78M
EPS, diluted
-$0.25
Free cash flow
–
Reported periodTrailing twelve months